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Abstract. Transcriptional regulation following mycobacteriophage I3 infection has been 
investigated. For this purpose, RNA polymerase mutants (rifr) of host bacterium, 
Mycobacterium smegmatis have been isolated and characterised. Phage growth in rifs and 
rifr cells in presence of rifampicin revealed the involvement of host RNA polymerase in 
phage genome transcription. This was confirmed by studies on in vivo RNA synthesis as well 
as by direct RNA polymerase assay after phage infection. Significant stimulation in RNA 
polymerase activity was seen following phage infection. The maximal levels were attained in 
about 60 min post infection and maintained throughout the phage development period. The 
stimulation of polymerase activity was most pronounced when the phage DNA was used as 
the template. RNA polymerases from uninfected and phage-infected Mycobacterium 
smegmatis have been purified to homogeniety. The enzyme purification was accomplished 
by a rapid procedure utilising affinity chromatography on rifampicin-Sepharose columns. 
Subunit structure analysis of the purified RNA polymerase from uninfected and phage- 
infected cells showed the presence of α, β, β' and σ subunits similar to the other prokaryotic 
RNA polymerases. In addition, a polypeptide of 79,000 daltons was associated with the 
enzyme after phage infection. The enzymes differed in their properties with respect to 
template specificity. Phage 13 DNA was the preferred template for the modified RNA 
polymerase isolated from infected cells which may account for the transcriptional switch 
required for phage development. 
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Introduction 
 
Infection with bacteriophages brings about dramatic changes in the intracellular 
environment of host bacteria. These major adaptations assure specific, rapid and 
temporally correct transcription needed for the phage growth and multiplication. 
Bacteriophages are known to invoke novel transcriptional controls, thereby regu- 
lating their genome transcription (Doi 1977; Travers, 1976). 
We have employed Mycobacterium smegmatis-phage 13 system as a model to study 
host-virus interaction. Mycobacteriophage 13 is a temperate, transducing phage with 
a growth cycle in the synthetic medium lasting for 5 h comprising of a 200 min latent 
period and a 60–90 min rise period (Nagaraja and Gopinathan, 1980). In conformity 
with the slow growing nature of their hosts, the mycobacteriophages also show 
prolonged growth patterns. The host DNA is not degraded after phage 13 infection 
until the end of intracellular development period (Nagaraja and Gopinathan, 1981). 
Evidently, the phage must be exerting control at the level of RNA synthesis by 
diverting the host transcriptional machinery towards its own transcription. This 
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transcriptional control has, therefore been investigated in detail. The results 
presented in this communication show that phage 13 is employing the host RNA 
polymerase for its genome transcription, after suitably modifying the enzyme. The 
RNA polymerase isolated from phage-infected cells differs markedly from the one 
isolated from uninfected bacteria in subunit structure and template specificity. 
 
 
Materials and methods  
 
Chemicals 
 
Nucleoside triphosphates (ATP, GTP, CTP, UTP), calf thymus- and salmon sperm 
DNA, poly d(A-T), poly (G-U), rifampicin (rif), bovine serum albumin (BSA 
fraction V, recrystallised), dithiothreitol (DTT), dimethylsulphoxide (DMSO), 
sodium dodecyl sulfate (SDS) and l-ethyl-3(3-dimethyl aminopropyl) carbodiimide 
(EDC) were from Sigma Chemical Company, St. Louis, Missouri, USA. [3H]-Uracil 
was from Bhabha Atomic Research Centre, Bombay. [3H] -UTP was from New 
England Nuclear, Boston, Massachusetts, USA. 
 
Bacteria and phage 
 
A clear plaque forming mutant of phage 13 (Gopinathan et al., 1978) was employed 
for all the experiments described here. The host strain used was M. smegmatis SN2. 
The bacteria and phage were grown as described elsewhere (Nagaraja and Gopinathan, 
1980). 
Rifampicin-resistant M. smegmatis cells were isolated by mutagenesis using N- 
methyl-N' -nitro-N-nitrosoguanidine (NTG). Bacteria growing in exponential phase 
were harvested, suspended in minimal medium containing 200 µg/ml of NTG and 
incubated for 45 min at 37°C. The cells were washed free of the mutagen, inoculated 
into nutrient broth and were grown overnight. The drug resistant colonies were 
selected on nutrient agar plates containing 100 µg/ml rifampicin. 
For growth or inhibition studies, rifampicin was added to the cultures from a 
stock solution (4 mg/ml) in DMSO. Appropriate volume of DMSO was present in 
control cultures. 
 
Preparation of cell free extracts 
 
The cells were washed twice with extraction buffer (20 mM Tris-HCl, pH 7·4, 5 mM 
MgCl2, 5 mM β-mercaptoethanol and 10% glycerol) and suspended in the same 
buffer. Extracts were prepared by passing the cell suspension through French 
pressure cell (18000 psi) followed by centrifugation at 2,000 g for 30 min. The 
supernatent was further centrifuged at 100,000 g for 90 min and this S-100 
supernatent was used for all the enzyme assays. 
 
Purification of RNA polymerase 
 
The S-100 fraction from uninfected or 90 min post-infection cells of M. smegmatis 
was fractionated with ammonium sulphate, with pH maintained at 7·5. The protein 
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fraction precipitating between 30 and 50% saturation of ammonium sulphate was 
dissolved in a small volume of buffer A (10 mM Tris-HCl, pH 7·9, 1 mM MgCl2, 
0·1 mM DTT and 5% glycerol), and gel filtered on an Ultrogel column (1·2 × 70 cm), 
previously equilibrated with buffer A. The individual fractions (1·2 ml) were 
monitored for absorbance at 280 nm and enzyme activity. The active fractions were 
pooled and subjected to affinity chromatography on rifampicin-Sepharose column. 
 
 
Preparation of rifampicin-Sepharose 
 
AH-Sepharose (1·2 g) was washed with 0·5 M NaCl, suspended in 3·0 ml of water and 
20 µmol of rifampicin dissolved in 40% dimethylformamide was added. The pH 
was adjusted to 4·5-6·0, and gently shaken for 2 h maintaining the pH between 
4·5–6·0. EDC (200 µmol) was added, and the shaking was continued at room 
temperature (20°C) for 18–20 h. The reaction was continued for another 10 h in the 
presence of additional 200 µmol EDC, at the end of which 100 mg of glycine was 
added. After shaking for 1 h, the contents were washed successively with the 
following: (i) 100 ml of water, (ii) 100 ml of 0·1 M sodium acetate in 0·5 M NaCl 
(pΗ 4·5), (iii) 100 ml of 2 M urea in 0·5 M NaCl, (iv) 100 ml of 0·1 M sodium 
bicarbonate in 0·5 M NaCl, pH 9·5 and (v) excess of water. 
The coupled rifampicin-Sepharose (light orange-red in colour) was stored in 
0·5 M NaCl at 4°C, protected from light. Rifampicin-Sepharose was packed into a
column and equilibrated with buffer A containing 50 mM KCl. The coupled 
rifampicin-Sepharose was relatively unstable, due to the degradation of the drug. 
However, if stored at 40C, the column could be used 2–3 times within a week. After 
each use, the column was washed alternately with low pH and high pH buffers 
containing 0·5 M NaCl. 
 
 
RNA polymerase assay 
 
The reaction was carried out essentially as described by Burgess (1969). The assay 
mixture contained in 125 µl, 20 mM Tris-HCl, pH 7·9, 1 mM magnesium acetate, 
0·1 mM EDTA, pH 7·0, 0·1 mM DTT, 200 mM KCl, 0·4 mM potassium phosphate 
pH 7·5, 2·5 µg BSA, 1% glycerol, 0·4 mM each of CTP, ATP and GTP, 0·1 mM [3H ]-
UTP (200 µCi/µmol), 5 µg calf thymus DNA and the enzyme. Potassium phosphate 
was added to the assay mixture to inhibit polynucleotide Phosphorylase (Burgess 
1969); the presence of phosphate had no adverse effect on polymerase activity. The 
reaction mixtures were incubated at 37° for 5 min and 100 µ1 samples were processed 
for the determination of trichloracetic acid-insoluble radioactivity. 
One unit of enzyme activity incorporated 1 nmol of UMP in 5 min under the 
conditions described. Protein estimation was carried out by the method of Lowry et 
al. (1951). 
 
 
Polyacrylamide gel electrophoresis 
 
Polyacrylamide gel electrophoresis (PAGE) under non-denaturing conditions was 
carried out as described by Smith and Braun (1978) with slight modifications. Apart 
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from the regular constituents, the 5% acrylamide gels contained 5 mM ß-mercapto- 
ethanol and 10% glycerol in Tris-glycine (pH 8·3). After electrophoresis the gels 
were stained and destained as described by Fairbanks et al. (1971). SDS-PAGE was 
carried out by the method of Laemmli (1970) in 7·5% gels. The gels were scanned at 
280 nm using UV-190 Shimadzu double beam spectrophotometer, to determine the 
number of subunits. 
 
Molecular weight determination 
 
Molecular weight of the subunits was calculated based on the mobility of reference 
markers—albumin (bovinc plasma), ovalbumin, pepsin, β-lactoglobulin and 
lysozyme. 
 
Results 
 
Isolation and characterization of rif r mutants of M. smegmatis 
 
Experiments were designed to see whether phage 13 is employing the host RNA 
polymerase or coding for its own enzyme. For this purpose, RNA polymerase 
mutants (rifr)0 of M. smegmatis were isolated and characterized. All the mutants grew 
at 100 µg/ml or more of rifampicin, while the growth of the parental strain was 
completely inhibited by less than 1 µg/ml of rifampicin. However, the drug resistant 
strains showed a lag in their growth, which was even more pronounced in the 
presence of the drug. To rule out the possibility that the rifrr mutation was at the level 
of permeability to the drug into the organism, the growth of the strains was 
examined in the presence of the antibiotic and 0·01 % SDS. At this concentration,
SDS renders the cells permeable to the drug without exerting any growth inhibitory 
effect by myself. All the mutants isolated in the present studies were resistant to the 
drug even in the presence of SDS. 
To confirm that the mutation was indeed in RNA polymerase, the enzyme activity 
was assayed in cell-free extracts prepared from wild type and rifr  bacteria (table 1).
 
Table 1. Effect of rifampicin on RNA polymerase activity. 
The extracts were prepared from exponentially growing Dells of M  
smegmatis (uninfected or 90 min following the infection with phage I3). 
The S-100 fraction was used as enzyme source. The RNA polymerase 
reaction was carried out as described under methods. The enzyme was 
incubated with rifampicin for 5 min prior to the addition of the 
substrate. 
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More than 90 % inhibition of RNA polymerase activity was observed in the extracts 
from wild type (rif s) cells, before or after phage infection. In contrast, the enzyme 
isolated from the resistant cells was not inhibited by 100 µg/ml of rifampicin, 
establishing that the mutation was at the level of RNA polymerase. 
 
 
Phage is utilizing host RNA polymerase  for its transcription 
 
To find out whether the phage is dependent on the host RNA polymerase or coding 
for its own enzyme, the effect of rifampicin on phage production was examined. Wild 
type and rifrcells were infected with phage I3 and the production of phage at the end 
of 1 cycle of growth in the presence of rifampicin (added at different times), was 
monitored (figure 1). 
 
 
 
Figure 1. Effects of rifampicin on phage production. 
M. smegmatis, rif s and rif r strains were infected with phage 13. The infected samples were 
exposed to 100 µg/ml of rifampicin at diferent periods during growth and the growth 
continued till the end of 1 cycle (300 min). The phage titers were determined at the end of 
one cycle of phage growth. The rif r mutant used in this and all the subsequent experiments 
was resistant upto 500 µg/ml of the antibiotic. (●) , rifs,(∆), rif s . 
 
Phage production was completely inhibited in wild type cells when rifampicin was
added at any time during the phage development period (up to 160 min, in nutrient 
broth). On the contrary, no inhibition of phage growth was observed in rifr cells, 
irrespective of the presence of drug. These results implied that in sensitive cells, 
inhibition of host RNA polymerase has resulted in the inhibition of transcription 
from phage genome. Phage production was not affected in the rif r cells in the 
presence of rifampicin due to insensitivity of the enzyme to the drug. 
To establish this point firmly, the in vivo RNA synthesis was also examined in rifs
and rifr cells after phage infection. [3H]-Uracil incorporation into RNA was 
completely blocked by rifampicin in wild, type cells (figure 2). The extent of inhibition 
of RNA synthesis in the rifr mutant was much less pronounced. The reduced level of 
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Figure 2.. In vivo RNA synthesis in rif s  and rif r bacteria. 
[3H]-Uracil incorporation into RNA was measured during the period of phage 
development in the presence of rifampicin (100 µg/ml). [3H]-Uracil (1 µCi/ml) was added at 
the time of infection. Samples were removed at different times and the acid precipitable 
radioactivity was determined. 
Top panel: Synthesis in rifs cells. 
Bottom panel: Synthesis in rif r cells. 
(O), Control (no drug); (●), 100 µg/ml rifampicin. 
 
RNA synthesis in rif r cells was consistent with the reduced growth of this strain. 
These results confirmed that the phage is employing host RNA polymerase for its 
genome transcription. 
Further support for this conclusion comes from the in vitro RNA polymerase
reaction carried out with extracts prepared from phage-infected cells (see table 1).
These results also rule out that phage 13 codes for its own polymerase for the
following reasons. For instance, if the phage was coding for a rifampicin-resistant
enzyme, there should not be complete inhibition of RNA polymerase activity in rifs
cells infected with phage. It is evident from table 1, that there was complete 
inhibition. On the other hand, if phage was inducing a rifampicin sensitive enzyme, 
inhibition of the enzyme should be expected in the presence of the drug even in rifr cells. 
There was no inhibition of activity from phage-infected rif rcells (table 1). 
 
RNA polymerase was stimulated after phage infection
 
RNA polymerase activity in the phage infected cells was higher compared to the 
uninfected cells (table 1). The pattern of increase in the enzyme activity after phage 
infection was monitored and the results are presented in figure 3. The enzyme 
activity increased from early times after infection, reaching the maximal values 
around 60 min. The extent of stimulation was 4-6 fold in different sets of experiments 
and was seen till the end of latent period. Significantly the stimulation was more 
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Figure 3. RNA polymerase activity after phage 13 infection. 
M. smegmatis in exponential phase (1 × 108 cells/ml) was infected with phage I3 at a 
multiplicity of infection 15 in the presence of 1 mM CaCl2 and incubated at 37°C on a 
shaker. The cells were removed just prior to or after phage infection at the intervals noted. 
The latent phase of phage 13 growth gets over at 180 min. RNA polymerase assay with 
templates, (∆), phage 13 DNA and (O) calf thymus DNA;(●) in the presence 100 µg/ml 
refampicin with either of the templates. 
 
pronounced when phage 13 DNA was used as a template instead of calf thymus 
DNA. The levels of RNA polymerase remained constant in the uninfected cells in the 
entire duration of the experiment. 
 
Purification of RNA polymerases  from uninfected and phage I3-infected M. smegmatis 
 
All the above data suggested that phage I3 is employing host RNA polymerase for its 
transcription. The obvious question, therefore, is whether the phage is utilising the 
host enzyme as such or with modifications. To ascertain this point, RNA polymerase 
was purified from uninfected and phage I3 infected M. smegmatis cells. 
A rapid, 3 step procedure was developed for the purification of RNA polymerase. 
The steps employed were ammonium sulphate fractionation, Ultrogel filtration and 
affinmyy chromatography on rifampicin-Sepharose. The results of purification are 
summarised in tables 2 and 3. 
The mycobacterial enzyme, like the other prokaryotic RNA polymerases emerged 
immediately after the void volume from the gel filtration column as a high molecular 
weight protein. The enzyme was bound to the affinmyy column (rifampicin-Sepharose) 
very tightly and was eluted only at 1·2 M KCl (figure 4). Under similar conditions, 
the enzyme from Escherichia coli was eluted from this column at 0·6 M KCl. 
The purification methods developed here resulted in electrophoretically 
homogeneous preparations of the enzyme from M. smegmatis (figure 5). The enzyme 
yields from phage-infected and uninfected cells were 10-16% and the increase in 
specific activity was 160–260 fold. The E. coli enzyme also appeared to be nearly 
homogeneous. 
 
RNA polymerase  from infected cells contains an additional component 
 
The subunit structure of the enzyme was determined by SDS-PAGE (figure 6). The 
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Table 2. RNA polymerase purification from M. smegmatis*. 
M. smegmatis in exponential phase (1 × 108 cells/ml) was used for the preparation of enzyme.
*From 12 g wet weight of cells. 
**The total activity at this stage was considerably more than the earlier steps, due to the removal of
inhibitory materials.
 
 
 
Table 3. RNA polymerase purification from phage I3-infected M. smegmatis*. 
M. smegmatis, in exponential phase was infected with phage I3 at a multiplicity of infection of 15 in 
presence of 1 mM CaCl2 and incubated for 90 min at 37°C on a shaker before the cells were harvested for 
the isolation of the enzyme. 
*From 12 g wet weight of cells. 
**The total activity at this stage was considerably more than the earlier steps, due to the removal of 
inhibitory materials. 
 
 
 
RNA polymerase from uninfected cells showed 3 bands corresponding to molecular 
weight of 151,000, 95,500 and 45,500. These bands were tentatively identified as β β', 
σ and α subunits by analogy to the molecular weight of known prokaryotic RNA 
polymerases. The enzyme from infected cells had an extra band of molecular weight 
79,000 in addition to other subunits. The total molecular weights of the RNA 
polymerases based on an α2 ββ'σ subunit structure correspond to 488,500 and 
564,500 respectively, from uninfected and phage I3-infected M. smegmatis (cf. total 
molecular weight of E. coli RNA polymerase is 493,000, Burgess, 1969). 
The pure enzymes from M. smegmatis (uninfected or phage I3-infected), were 10 
times more sensitive to inhibition by rifampicin, than the E. coli enzyme. At 10-8 Μ 
rifampicin the former was inhibited 65–75% while the E. coli enzyme was not 
affected; at 10–7 Μ drug concentration, all of them were inhibited. 
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Figure 4.  Affinity chromatography of RNA polymerases on rifampicin-Sepharose column 
 Protein fractions from Ultrogel filtration step showing enzyme activity were pooled and 
loaded on to the affinity column. After washing the column extensively with buffer A 
containing 0·1 M KCl, the enzyme was eluted using a step gradient of KCl (0·2–1·2 M) in 
buffer A. One ml fractions were collected and assayed for enzyme activity. 
Top panel: RNA polymerase from uninfected M. smegmatis. 
Middle panel: RNA polymerase from phage 13 infected M. smegmatis. 
Bottom panel: RNA polymerase from E. coli. 
 
 
 
Template specificity 
 
To check whether the association of the extra polypeptide with RNA polymerase 
could account for changes in transcriptional specificmyies, the template recognition by 
the modified and the parental enzymes was compared (table 2). The enzyme from 
phage-infected cells transcribed phage 13 DNA to a much greater extent than all 
other template DNAs tested. Calf thymus- and salmon sperm DNAs also served as 
good templates for this enzyme, while the host DNA turned out to be poor template. 
On the other hand, no such specificmyy was observed for the RNA polymerase from 
uninfected cells. Single stranded DNA or synthetic ribopolymers were very poor 
templates for both the enzymes. 
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Figure 5.  PAGE of RNA polymerases. 
The electrophoresis was carried out in 5% gels at pH 8·8; 10 µg of enzyme after rifampicin-
Sepharose affinity chromatography, was used in each gel. From left to right, RNA 
polymerases from uninfected- and phage I3-infected M . smegmatis, and E. coli. 
 
 
Discussion 
 
When bacteria are infected with phage, often a metabolic shift takes place 
channelling the macromolecular syntheses towards the phage development. Involve- 
ment of RNA polymerase in the regulation of transcriptional switch has been well 
documented and is primarily responsible for metabolic alterations in certain cases 
(Losick and Chamberlin, 1976; Doi, 1977). Different bacteriophages have evolved 
varying means of transcriptional control. Transcription of λ genome is regulated by 
antitermination phenomenon (Adhya et al., 1976). Extensive changes have been 
observed in the subunit structure of host RNA polymerase after infection with 
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Figure 6. Subunit structure of RNA polymerase. 
The purified enzymes were subjected to electrophoresis on 7·5% Polyacrylamide gels
under denaturing conditions. After electrophoresis the gels were scanned at 280 nm.
Top panel: RNA polymerase from phage-infected M. smegmatis. 
Bottom panel: RNA polymerase from uninfected M. smegmatis. 
(ßß' subunits do not separate well on 7·5% gels; see Bautz, 1976 and Wiggs et al., 1979) 
 The molecular weights of the subunits were determined from the mobility of reference
markers. 
 
Table 4. Template specificity of RNA polymerase. 
 
Partially purified enzyme, after Ultrogel fractionation step was used. 10 µg of protein
and 5 µg of different template DNAs (native) were used in each assay. RNA
polymerase reaction was initiated by the addition of substrates. Details of assay are
described in text. 
 
coliphages T4 and T5 (Stevens, 1972; Doi, 1977; Szabo et al., 1975). Similarly, 
infection with phages SP0l and SP82 results in altered promoter recognition and 
template specificity of RNA polymerase from Bacillus subtilis (Fox, 1976; Whitelay et 
al., 1976). A requirement for 5-hydroxymethyl uracil in DNA for the specific 
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transcription by the phage SP0l-modified (gene 28-product associated) RNA 
polymerase has been reported (Lee et al., 1980). Coliphages T3 and T7 code for their 
own polymerases (Bautz, 1976; Doi, 1977) which carry out the transcription from 
late promoters. Another kind of mechanism is seen in coliphage N4 (Falco et al., 
1977, 1978) and phage PBS2 of B. subtilis (Clark et al., 1974). These viruses have the 
RNA polymerase in the particles and is presumably injected into the host cell along 
with the DNA. The results presented in this paper clearly establish that the host 
RNA polymerase carries out phage I3 DNA transcription. Comparison of the 
structure of enzymes purified from uninfected and phage-infected cells show that the 
enzyme is in modified form after infection. A new polypeptide is found associated to 
the enzyme, in addition to the other subunits. The significant changes observed in 
vitro in the template specificity could be due to the binding of this factor to the host 
enzyme as no other changes were apparent in the enzyme structure. 
The RNA polymerases from uninfected and phage I3-infected M. smegmatis bind 
to rifampicin-Sepharose column very tightly as seen from their elution profile. On 
the contrary, the RNA polymerase from E. coli is eluted at a much lower 
concentration of KCl indicating the lower affinity of this enzyme to rifampicin. This 
is consistent with the 10–100 fold higher sensitivity of mycobacterial enzymes to 
rifampicin, reported here and earlier for M. tuberculosis (Harshey and 
Ramakrishnan, 1976). However, mycobacterial enzyme seems to have less affinity 
towards heparin, because the enzyme is eluted from heparin-Sepharose column at a 
low salt (0·2 M KCl) concentration (data not shown). The procedure developed for 
purification of RNA polymerase is very rapid and the pure enzyme is obtained 
within 48 h. Although several procedures are available for the purification of RNA 
polymerases from prokaryotes, the method reported here using affinity chromato- 
graphy on rifampicin-Sepharose columns could be adopted as a general method for 
the rapid purification of RNA polymerase from small amounts of starting material. 
This is the first report of the use of rifampicin-Sepharose as an affinity matrix for the 
purification of RNA polymerase. 
Phage 13 DNA serves as the best template in vitro for the RNA polymerase from 
the phage-infected M. smegmatis. This immediately suggests the strong possibility 
that in vivo, the modified enzyme specifically transcribes phage 13 DNA, the bacterial 
DNA being less efficiently. On the other hand, RNA polymerases from various sources 
show differential transcription of different templates or a particular template (Iida et 
al., 1979; Wiggs et al., 1979). However, maximum specificity is seen only with the 
phage-induced polymerases. For instance, enzymes from phages T3 and T7 
selectively transcribe their own DNA to the maximum extent (Bautz, 1976). Another  
extreme example is coliphage N4 (Falco et al., 1977, 1978). The purified N4 
polymerase transcribes single stranded N4 DNA very efficiency but not native 
double stranded DNA. Phage I3-modified polymerase seems to prefer native DNA 
templates. 
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